Lantern Pharma Inc   (LTRN)
Other Ticker:  


Lantern Pharma Inc

LTRN's Financial Statements and Analysis

Lantern Pharma Inc narrowed first quarter of 2023 net loss per share of $-0.36 compare to net loss per share of $-0.38 recorded in the same quarter a year ago a decrease compare to $-0.31 realized in previous quarter.

first quarter of 2023
Earnings Per Share Revenues
$ -0.36 $  0 Mill
$+0.02     Unch.    

Lantern Pharma Inc 's Revenue fell by 0 % in first quarter of 2023 (Mar 31 2023) year on year, to $0 million and declined by sequentially.

Lantern Pharma Inc is Expected to report next financial results on August 07, 2023.

More on LTRN's Income Statement

Lantern Pharma Inc 's in thefirst quarter of 2023 recorded net loss of $-3.868 million, an improvement compare to net loss of $-4.122 million in I. Quarter a year ago.

Sequentially net loss advanced

More on LTRN's Growth

Lantern Pharma Inc Inventories
In Mar 31 2023 company's net cash and cash equivalents decreased by $-5 million, capital expenditures fell by